Taysha Gene TherapiesTSHA 
$2.031.00%24h
1.00%24h
Global rank2898
Market cap$379.53M
Change 7d-20.70%
YTD Performance18.71%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Taysha Gene Therapies (TSHA)
As of December 2024, Taysha Gene Therapies has a market cap of $379.53M. This makes Taysha Gene Therapies the world's 2898th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Taysha Gene Therapies from 2020 to 2024
-
Value:-
Market cap history of Taysha Gene Therapies from 2020 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $292.59M | -11.58% |
| 2023 | $330.92M | -21.68% |
| 2022 | $422.53M | -80.60% |
| 2021 | $2.18B | -56.10% |
| 2020 | $4.96B | - |
TSHA Market Cap Today is $379.53M 1.00% - 18 Dec 2024
View largest stocks by market cap 
